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of the UGDH gene and may offer new approaches to investigate
its potential alteration in joint diseases, including osteoarthritis
and rheumatoid arthritis.
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ARTICULAR CARTILAGE CATABOLISM IN THE
PATHOGENESIS OF KASHIN-BECK DISEASE
J. Cao1, S. Li1, Z. Shi1, Y. Yue1, J. Sun1, C.E. Hughes2,
B. Caterson2
1Xi’an Jiaotong University, Xi’an, China, 2Cardiff University,
Cardiff, United Kingdom
Purpose: Kashin-Beck Disease (KBD) is an endemic, chronic,
degenerative osteoarthropathy which affects 2.5 million of 30
million people living in the KBD region of China. The symptoms
include joint pain, stiffness of the joints after getting up in the
morning, disturbances of flexion and extension in the elbows,
enlarged phalangeal joints and limited motion in the middle-
sized and large joints of the body. It manifests as cartilage
degeneration and necrosis, with pathological changes occurring
in growth plate and articular cartilage. At present the etiology
and pathogenesis of KBD is unclear. One of the most popular
hypotheses is that KBD is caused by mycotoxins. The other
etiologies include selenium deficiency in soil and water in KBD
area, nutrition deficiency and virus infection etc. However, all of
the hypotheses lack adequate experimental evidence to support
any particular conclusion. This study investigated the extracellu-
lar matrix metabolism in cartilage and serum levels of IL-1 beta,
TNF-alpha, MMP-1 and CD44 in serum of KBD patients.
Methods: Immunohistochemical analyses of normal and KBD
patient cartilage (16 adults and 4 children and normal age-
matched patient tissue 4 adults and 3 children) was per-
formed using a monoclonal antibody recognising CD44, the
IGD aggrecase-generated neoepitope (monoclonal antibody BC-
13 recognising ... EGE373) and monoclonal antibody 3-B-3(-)
which recognizes thee nonreducing terminal of CS chains in
osteoarthritic cartilage. In addition, the serum levels of soluble
CD44 (sCD44), IL-1 beta, TNF-alpha and MMP-1 were deter-
mined in KBD patients (20 adults and 18 children) and normal
patients (20 adults and 18 children) using a competitive ELISA.
Results: Toluidine Blue and Saffron O staining indicated there
was a proteoglycan loss in both of KBD children and adult carti-
lage. Strong immunohistochemical staining for CD44 occurred in
14 of 16 adult KBD patients with moderate staining present in the
remaining two patients. Similarly, strong CD44 immunostaining
occurred in 3 of the 4 KBD children with moderate staining in the
fourth KBD child. In contrast, weak CD44 immunostaining was
only found in two of the four normal adult cartilage and none of
the three normal child samples. Immunohistochemical staining
with MAb BC-13 and 3-B-3(-) showed an intensive staining in
both of KBD children and adult cartilage when compared with
the normal cartilage samples. Furthermore, statistically signifi-
cant elevated levels of sCD44, IL-1 beta and TNF-alpha were
found in the sera of both adult and child KBD patients when
compared to serum levels of normal adult and child controls.
However, there was no difference in MMP-1 level between KBD
and normal children.
Conclusions: Our results demonstrate that altered IL-1 beta,
TNF-alpha, aggrecan and CD44 metabolism occurs in the
pathogenesis of KBD and there is an increased aggrecanase-
generated proteoglycan loss from KBD adult and children carti-
lage. These primary metabolic changes are a contributing factor
causing pathology in joint formation and instability which in turn
leads to the onset of secondary osteoarthropathy in the major
load-bearing joints of KBD patients.
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PROTECTIVE ABILITIES OF INTERLEUKIN-10 IN
BLOOD-INDUCED CARTILAGE DAMAGE
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F.P. Lafeber
UMC Utrecht, Utrecht, The Netherlands
Purpose: Joint bleeds occur frequently in patients suffering from
haemophilia or can occur as a consequence of a trauma. It
has been demonstrated that even a limited number of bleeds in
time leads to severe joint damage. With respect to the mech-
anisms of blood induced joint damage, we have demonstrated
that monocytes/macrophages within the mononuclear cell pop-
ulation together with the red blood cells as present in blood
are responsible for the irreversible inhibition of cartilage matrix
synthesis. Small amounts of IL-1 that are produced by activated
monocytes/macrophages increase the production of hydrogen
peroxide (H2O2) by chondrocytes. The hydrogen peroxide reacts
with haemoglobin-derived iron from damaged and phagocytosed
red blood cells, which results in the formation of hydroxyl radicals
in the vicinity of chondrocytes. This leads to chondrocyte apop-
tosis and with that the irreversible inhibition of cartilage matrix
synthesis.
In search of possible interventions to prevent or limit the cartilage
damaging effects of joint bleeds, we tested interleukin-10 (IL-
10) as an inflammation-controlling cytokine on blood-induced
cartilage damage.
Methods: Healthy human articular cartilage tissue explants were
cultured in the presence or absence of 50% v/v blood for 4 days,
followed by a recovery period of 12 days. IL-10 was added in
0.1, 1 or 10 ng/ml. The effect on cartilage matrix proteoglycan
synthesis, -release, and -content were determined.
Results: IL-10 was able to prevent the decrease in proteoglycan
synthesis and the increase in proteoglycan release of cartilage
exposed to blood dose dependently. As a consequence, the
decrease in proteoglycan content after blood exposure could be
prevented dose dependently. With 10 ng/ml IL-10, which is still a
low dose for local therapeutic treatment, at least 50% reduction
in adverse effects was observed.
Conclusions: The present results show that interleukin-10 pre-
vents the direct harmful effects of blood on articular cartilage.
This effect of IL-10, in addition to its anti-inflammatory prop-
erties, may add to prevention of irreversible degenerative joint
damage as a consequence in time of joint haemorrhages. Al-
though treatment studies in addition to prevention studies have
to be performed, IL-10 might be of use for local treatment of joint.
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Purpose: To verify the involvement of proinflammatory cytokines
IL-17, IL-1β and TNF-α in cartilage vascularization on the pro-
duction of vascular endothelial growth factor (VEGF) by chondro-
cytes isolated from patients with osteoarthritis (OA), rheumatoid
arthritis (RA) and patients with femoral neck fracture (FP), and
to evaluate the production of VEGF by chondrocytes freshly iso-
lated from patients with OA, in comparison with chondrocytes
redifferentiating in micromass.
Methods: Chondrocytes isolated from patients with OA were
maintained in monolayer culture for several passages. Chondro-
Osteoarthritis and Cartilage Vol. 14, Supplement B S97
cyte dedifferentiation was monitored by the synthesis of cathep-
sin B by these cells. Chondrocyte redifferentiation was studied
by micromass three-dimensional (3D) culture of freshly isolated
cells. Chondrocytes freshly isolated, at each monolayer subcul-
ture (subculture 1 to 3) and in 3D cultures were stimulated with
IL-17, IL-1β or TNF-α. Supernatants were collected, immunoas-
sayed for the production of VEGF and cathepsin B and assayed
as the source of VEGF on the VEGF sensible ECV304 cell
line. The cells were used to quantify intracellular cathepsin B
enzymatic activity.
Results: Freshly isolated chondrocytes maintained in 3D cul-
ture secreted amount of VEGF lower than in monolayer culture
and comparable with the amount of VEGF secreted by cells
in subculture 1. In 3D cultured chondrocytes the cathepsin B
synthesis shown a differentiation degree such as that of freshly
isolated chondrocytes. In differentiated conditions of freshly iso-
lated chondrocytes in monolayer, IL-1β and TNF-α, but not IL-17,
can inhibit the spontaneous secretion of VEGF by human OA,
RA and FP chondrocytes, and IL-17 can restore the decrease
in VEGF secretion caused by TNF-α. IL-17, together with IL-1β
and TNF-α, can enhance VEGF secretion to various extents by
dedifferentiated OA chondrocytes. This change in effect with re-
spect to primary culture was observable for all cytokines at the
beginning of dedifferentiation, when the production of VEGF by
chondrocytes had dramatically fallen and the cathepsin B syn-
thesis had increased. The amount of VEGF induced by cytokines
on dedifferentiated chondrocytes never reached the amount of
VEGF produced by differentiated chondrocytes. In contrast with
freshly isolated chondrocytes cultured in monolayer, TNF-α was
able to enhance VEGF secretion by chondrocytes in 3D culture.
VEGF produced by chondrocytes stimulated the ECV304 cell
line proliferation.
Conclusions: These results indicate that freshly isolated chon-
drocytes maintained in 3D culture secrete VEGF but show some
characteristics of chondrocytes from monolayer subculture. Ded-
ifferentiated OA chondrocytes secrete VEGF after stimulation
with proinflammatory cytokines and this event may be responsi-
ble for neovascularization found in OA cartilage.
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FUNCTIONAL ANALYSES OF MMP-28 AND ADAMTS-16
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Purpose: MMP-28 (epilysin) and ADAMTS-16 are recently dis-
covered members of the matrix metalloproteinase and ‘a disinte-
grin and metalloproteinase domain with thrombospondin motifs’
families respectively. We have previously reported expression of
MMP28 and ADAMTS16 in normal human articular cartilage and
significant induction of expression in osteoarthritis. The physio-
logical function and substrates of MMP-28 or ADAMTS-16 are
currently unknown.
Methods: Expression constructs for wild-type proteinases and in-
active mutants were cloned into pcDNA4-FLAG. Protein expres-
sion after transfection into a variety of cell types was assessed by
western blotting. Stable cell lines were generated using SW1353
chondrosarcoma cells and C28/I2 immortalized chondrocytes
were generated by transfection with linearised vector and zeocin
selection; clonal lines were then generated. Processing events
were probed using both furin and MMP inhibitors. Functional
analyses included cell proliferation, adhesion and migration.
Results: HeLa cells transiently transfected with full length
MMP28 cDNA showed strong expression of MMP-28. Cell
lysates contained pro-MMP-28, conditioned medium contained
pro-MMP-28 and a cleaved C-terminal domain, and ECM frac-
tions contained some pro-MMP-28 and also the active form.
Using a furin inhibitor, we found that the activation of MMP-28
was furin dependent. Addition of an MMP inhibitor showed the
MMP-dependence of cleavage of the C-terminal domain, but
comparison with the EA mutant MMP-28 suggested that this
was not due to autoproteolysis. Stable expression of MMP-28
in chondrocyte cell lines increased the capacity to adhere to a
number of extracellular matrix components. Similar experiments
are ongoing with ADAMTS-16 expressing cell lines.
Conclusions: In initial studies to characterise the biochemistry
and function of MMP-28 and ADAMTS-16, we observed that the
activation of pro-MMP-28 is furin dependent. Interestingly, the
active enzyme preferentially associates with the ECM. This may
suggest a matrix substrate for MMP-28. We have successfully
generated SW1353 and/or C28/I2 cell lines stably transfected
with MMP28 (full length, EA mutant and pro-cat) and ADAMTS-
16 (full-length and EQ mutant). A more complete analysis includ-
ing adhesion, migration and proliferation assays, as well as in
candidate protein and proteomic screens of potential substrates
is currently underway.
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β1-INTEGRIN REGULATION OF
MECHANOTRANSDUCTION IN OSTEOARTHRITIC
HUMAN ARTICULAR CHONDROCYTES
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Purpose: Normal and osteoarthritic (OA) human articular chon-
drocytes (HAC) respond to 0.33 Hz cyclical mechanical stimu-
lation (MS) via a α5β1 integrin mediated mechanotransduction
pathway although downstream signalling pathways are different.
In both normal and OA cells, the pathway involves tyrosine ki-
nase activity and protein kinase C (PKC). However, while normal
HAC respond to 0.33 Hz mechanical stimulation with increases
in aggrecan gene expression and cell membrane hyperpolarisa-
tion, in OA HAC aggrecan mRNA levels are unchanged and a
cell membrane depolarisation response is observed.
Experiments were performed utilising a panel of function-
modifying antibodies to investigate whether modulation of β1
integrin function influenced OA chondrocyte mechanotransduc-
tion.
Methods: OA HAC were incubated with the function modifying
anti-β1 integrin receptor antibodies JB1a, P4C10 and TS2/16 for
30 min prior to 0.33 Hz MS. Membrane potentials were assessed
before and after addition of the relevant antibody and following
MS. RNA was extracted 24 hours post-MS and relative levels of
aggrecan mRNA were assessed by semi-quantitative RT-PCR.
PKC translocation and FAK phosphorylation in response to MS
were assessed by western blotting.
Results: Following MS, OA cells exhibit significant cell mem-
brane depolarisation. Treatment with JB1a and P4C10 for 30
minutes did not alter cell membrane potential, but treatment with
TS2/16 caused significant cell membrane depolarisation. Both
JB1a and P4C10 inhibited MS induced cell membrane depolari-
sation and MS had no effect on TS2/16 induced cell membrane
deplolarisation.
Treatment with anti β1 integrin antibodies for 30 minutes did not
alter aggrecan mRNA levels, however, following 24 hours anti-
body incubation significant decreases in aggrecan mRNA levels
were seen with P4C10 but not JB1a or TS2/16. Following MS,
there was no alteration in aggrecan mRNA levels in untreated
OA cells or cells treated with TS2/16 and MS had no effects on
